Navidea Biopharma (NAVB) Files 300K Common Shelf for Shareholder
Tweet
Share
E-mailGet Alerts NAVB Hot Sheet
Join SI Premium – FREE
Navidea Biopharmaceuticals (AMEX: NAVB) filed a registration with the U.S. SEC to sell, from time to time, up to 300,000 shares of its Common Stock on behalf of a selling shareholder.
Navidea will not receive proceeds from the sale.
Navidea will not receive proceeds from the sale.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Singularity Future Technology closes $5M registered direct offering
- Kairos Pharma announces 1-for-7 reverse stock split
- RenovoRx regains Nasdaq minimum bid price compliance
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
